What Happened: ORDAN's recent move involves selling 23,000 shares of Pediatrix Medical Group. This information is documented in a Form 4 filing with the U.S. Securities and Exchange Commission on ...

Despite Henry Schein’s underperformance relative to its peers, Wall Street analysts remain moderately optimistic about the ...

The ASX Healthcare sector has finished the week of December 19, 2025 down 1.6% with few signs of a much needed Christmas ...

Get the latest on Alcon's pending acquisition of LENSAR—deal updates, regulatory hurdles, and investment outlook.

Clover Health Investments CLOV is well poised for growth in the coming quarters, courtesy of its broad product spectrum. This ...

Tenet Healthcare (THC) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...

In 2024 and 2025, the MedTech sector has operated against a backdrop of a global economy marked by slowing growth, moderating ...

The DMK may consider a two-tier campaign, where they keep the focus on Chief Minister Stalin, as a senior statesman with ...

Coda Octopus Group’s patented 4D sonar tech and strong financials may drive high-margin growth. Read here for an analysis of ...

Morning Brief host Julie Hyman breaks down November's Consumer Price Index (CPI) report while covering the top market stories ...

Market sentiment toward Globus Medical received a significant boost following the latest round of analyst commentary. Two ...

Paramount last week took its case directly to Warner Bros shareholders, arguing that it has arranged "air-tight financing" to ...